Evaluation of the Effect of Topical Prostaglandin Analog Treatment on Orbital Structures in Open-Angle Glaucoma with Computed Tomography

ArticleAçık Erişim

Özet

Background/Objectives: This study aims to evaluate the computed tomography (CT) scans of glaucoma patients using prostaglandin analogs (PGA) in one eye, investigate findings associated with prostaglandin-associated periorbitopathy (PAP), and compare these findings with those of the contralateral eyes. Methods: Patients with open-angle glaucoma who had CT images of the orbital region taken for another reason at least one month after starting PGA treatment in one eye were included in the study. Enophthalmos measurements from thin-slice CT images, along with 3D volume measurements of orbital fat tissue, periorbital muscles, and the optic nerve, were performed. Ophthalmological examination findings and treatment information were collected. The values were compared with those of the contralateral eyes of the same patients not using PGA. Intraclass correlation coefficients (ICCs) were computed to evaluate measurement repeatability. Results: Forty patients were included in the study. Among them, 29 (72.5%) used latanoprost, 9 (22.5%) used bimatoprost, and 2 (5%) used travoprost. The mean enophthalmos values on the treated side (15.5 ± 2.0 mm) were lower than on the untreated side (16.1 ± 1.4 mm), but this difference was not statistically significant (p = 0.07). In 29 patients (72.5%), enophthalmos measurements were smaller on the treated side, with 7 patients (17.5%) showing a difference of 2 mm or more. No significant correlation was found between the duration of PGA use and enophthalmos measurements (p = 0.768 r = −0.048). Additionally, no significant differences were found in orbital fat volume, total extraocular muscle volume, and optic nerve volume (p > 0.05). ICC values demonstrated excellent reliability (ICC > 0.75) for all measurements. Conclusions: We did not find significant differences in enophthalmos measurements, orbital fat volume, total muscle volume, and optic nerve volume between the PGA-treated and untreated eyes. © 2024 by the authors.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11282Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.3390/jcm13195808Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorDurmuş Ece, Berire Şeyma
dc.contributor.authorYozgat, Zübeyir
dc.contributor.authorBayramlı, Hüseyin
dc.contributor.authorEce, Bunyamin
dc.contributor.authorAydin, Sonay
dc.date.accessioned2026-10-18T20:26:21.299387272Z
dc.date.available2026-10-18T20:26:21.299387272Z
dc.date.issued2024
dc.description.abstractBackground/Objectives: This study aims to evaluate the computed tomography (CT) scans of glaucoma patients using prostaglandin analogs (PGA) in one eye, investigate findings associated with prostaglandin-associated periorbitopathy (PAP), and compare these findings with those of the contralateral eyes. Methods: Patients with open-angle glaucoma who had CT images of the orbital region taken for another reason at least one month after starting PGA treatment in one eye were included in the study. Enophthalmos measurements from thin-slice CT images, along with 3D volume measurements of orbital fat tissue, periorbital muscles, and the optic nerve, were performed. Ophthalmological examination findings and treatment information were collected. The values were compared with those of the contralateral eyes of the same patients not using PGA. Intraclass correlation coefficients (ICCs) were computed to evaluate measurement repeatability. Results: Forty patients were included in the study. Among them, 29 (72.5%) used latanoprost, 9 (22.5%) used bimatoprost, and 2 (5%) used travoprost. The mean enophthalmos values on the treated side (15.5 ± 2.0 mm) were lower than on the untreated side (16.1 ± 1.4 mm), but this difference was not statistically significant (p = 0.07). In 29 patients (72.5%), enophthalmos measurements were smaller on the treated side, with 7 patients (17.5%) showing a difference of 2 mm or more. No significant correlation was found between the duration of PGA use and enophthalmos measurements (p = 0.768 r = −0.048). Additionally, no significant differences were found in orbital fat volume, total extraocular muscle volume, and optic nerve volume (p > 0.05). ICC values demonstrated excellent reliability (ICC > 0.75) for all measurements. Conclusions: We did not find significant differences in enophthalmos measurements, orbital fat volume, total muscle volume, and optic nerve volume between the PGA-treated and untreated eyes. © 2024 by the authors.
dc.identifier.doi10.3390/jcm13195808
dc.identifier.eissn2077-0383
dc.identifier.issn2077-0383
dc.identifier.issue19
dc.identifier.pmcidPMC11478186
dc.identifier.pmid39407871
dc.identifier.scopus2-s2.0-85206315713
dc.identifier.startpage5808
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11282
dc.identifier.volume13
dc.identifier.wosWOS:001333227100001
dc.language.isoen
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.ispartofJournal of Clinical Medicine
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectcomputed tomography
dc.subjectenophthalmos
dc.subjectglaucoma
dc.subjectprostaglandin analogs
dc.subjectprostaglandin-associated periorbitopathy
dc.subjectbeta adrenergic receptor blocking agent
dc.subjectbimatoprost
dc.subjectcarbonate dehydratase inhibitor
dc.subjectlatanoprost
dc.subjectlatanoprost plus timolol
dc.subjectprostaglandin derivative
dc.subjecttravoprost
dc.subjectaged
dc.subjectArticle
dc.subjectclinical article
dc.subjectcomputer assisted tomography
dc.subjectcontrolled study
dc.subjectcorrelation coefficient
dc.subjectextraocular muscle
dc.subjectfemale
dc.subjecthuman
dc.subjectimage analysis
dc.subjectmale
dc.subjectmuscle mass
dc.subjectopen angle glaucoma
dc.subjectoptic nerve
dc.subjectorbit
dc.titleEvaluation of the Effect of Topical Prostaglandin Analog Treatment on Orbital Structures in Open-Angle Glaucoma with Computed Tomography
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus3
rdl.citation.wos2
rdl.departmentDepartment of Radiology, Erzincan Binali Yıldırım University, Erzincan 24100, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)